Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts

M. Peracchi, F. Bamonti-Catena, B. Bareggi, R. Calori, A. T. Maiolo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To verify the clinical usefulness of extracellular cyclic nucleotide determinations as tumour markers in preneoplastic syndromes, plasma cyclic AMP (cAMP) and cyclic GMP (cGMP) levels were monitored in 47 patients with refractory anaemia with excess of blasts (35 RAEB and 12 RAEBt), 20 of whom progressed to acute leukaemia during the observation period. The control group consisted of 45 healthy subjects matched for age and sex. In all groups of patients plasma cAMP levels were within the normal range, whereas plasma cGMP levels were significantly higher than those of normal subjects in both RAEB and RAEBt patients, and increased further when progression to acute leukaemia occurred. These data suggest that serial determinations of plasma cGMP may be useful to monitor the progression of the disease, though there is no evidence that cGMP values at diagnosis may have a prognostic significance.

Original languageEnglish
Pages (from-to)177-180
Number of pages4
JournalBlut
Volume60
Issue number3
DOIs
Publication statusPublished - Mar 1990

Fingerprint

Refractory Anemia with Excess of Blasts
Cyclic Nucleotides
Cyclic GMP
Cyclic AMP
Leukemia
Tumor Biomarkers
Disease Progression
Healthy Volunteers
Reference Values
Observation
Control Groups

Keywords

  • Cyclic AMP
  • Cyclic GMP
  • Leukaemia
  • Myelodysplastic syndrome
  • RAEB

ASJC Scopus subject areas

  • Hematology

Cite this

Peracchi, M., Bamonti-Catena, F., Bareggi, B., Calori, R., & Maiolo, A. T. (1990). Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts. Blut, 60(3), 177-180. https://doi.org/10.1007/BF01720272

Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts. / Peracchi, M.; Bamonti-Catena, F.; Bareggi, B.; Calori, R.; Maiolo, A. T.

In: Blut, Vol. 60, No. 3, 03.1990, p. 177-180.

Research output: Contribution to journalArticle

Peracchi, M, Bamonti-Catena, F, Bareggi, B, Calori, R & Maiolo, AT 1990, 'Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts', Blut, vol. 60, no. 3, pp. 177-180. https://doi.org/10.1007/BF01720272
Peracchi M, Bamonti-Catena F, Bareggi B, Calori R, Maiolo AT. Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts. Blut. 1990 Mar;60(3):177-180. https://doi.org/10.1007/BF01720272
Peracchi, M. ; Bamonti-Catena, F. ; Bareggi, B. ; Calori, R. ; Maiolo, A. T. / Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts. In: Blut. 1990 ; Vol. 60, No. 3. pp. 177-180.
@article{c5d6a1e9a79745e795a2d38f387ef746,
title = "Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts",
abstract = "To verify the clinical usefulness of extracellular cyclic nucleotide determinations as tumour markers in preneoplastic syndromes, plasma cyclic AMP (cAMP) and cyclic GMP (cGMP) levels were monitored in 47 patients with refractory anaemia with excess of blasts (35 RAEB and 12 RAEBt), 20 of whom progressed to acute leukaemia during the observation period. The control group consisted of 45 healthy subjects matched for age and sex. In all groups of patients plasma cAMP levels were within the normal range, whereas plasma cGMP levels were significantly higher than those of normal subjects in both RAEB and RAEBt patients, and increased further when progression to acute leukaemia occurred. These data suggest that serial determinations of plasma cGMP may be useful to monitor the progression of the disease, though there is no evidence that cGMP values at diagnosis may have a prognostic significance.",
keywords = "Cyclic AMP, Cyclic GMP, Leukaemia, Myelodysplastic syndrome, RAEB",
author = "M. Peracchi and F. Bamonti-Catena and B. Bareggi and R. Calori and Maiolo, {A. T.}",
year = "1990",
month = "3",
doi = "10.1007/BF01720272",
language = "English",
volume = "60",
pages = "177--180",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts

AU - Peracchi, M.

AU - Bamonti-Catena, F.

AU - Bareggi, B.

AU - Calori, R.

AU - Maiolo, A. T.

PY - 1990/3

Y1 - 1990/3

N2 - To verify the clinical usefulness of extracellular cyclic nucleotide determinations as tumour markers in preneoplastic syndromes, plasma cyclic AMP (cAMP) and cyclic GMP (cGMP) levels were monitored in 47 patients with refractory anaemia with excess of blasts (35 RAEB and 12 RAEBt), 20 of whom progressed to acute leukaemia during the observation period. The control group consisted of 45 healthy subjects matched for age and sex. In all groups of patients plasma cAMP levels were within the normal range, whereas plasma cGMP levels were significantly higher than those of normal subjects in both RAEB and RAEBt patients, and increased further when progression to acute leukaemia occurred. These data suggest that serial determinations of plasma cGMP may be useful to monitor the progression of the disease, though there is no evidence that cGMP values at diagnosis may have a prognostic significance.

AB - To verify the clinical usefulness of extracellular cyclic nucleotide determinations as tumour markers in preneoplastic syndromes, plasma cyclic AMP (cAMP) and cyclic GMP (cGMP) levels were monitored in 47 patients with refractory anaemia with excess of blasts (35 RAEB and 12 RAEBt), 20 of whom progressed to acute leukaemia during the observation period. The control group consisted of 45 healthy subjects matched for age and sex. In all groups of patients plasma cAMP levels were within the normal range, whereas plasma cGMP levels were significantly higher than those of normal subjects in both RAEB and RAEBt patients, and increased further when progression to acute leukaemia occurred. These data suggest that serial determinations of plasma cGMP may be useful to monitor the progression of the disease, though there is no evidence that cGMP values at diagnosis may have a prognostic significance.

KW - Cyclic AMP

KW - Cyclic GMP

KW - Leukaemia

KW - Myelodysplastic syndrome

KW - RAEB

UR - http://www.scopus.com/inward/record.url?scp=0025208292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025208292&partnerID=8YFLogxK

U2 - 10.1007/BF01720272

DO - 10.1007/BF01720272

M3 - Article

VL - 60

SP - 177

EP - 180

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 3

ER -